To study the antibiotic use in children admitted to Intensive Care Unit
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Admitted to Pediatric Intensive Care Unit
- Registration Number
- CTRI/2017/01/007718
- Lead Sponsor
- Dept of Clinical Pharmacology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion Criteria
Patients newly admitted to pediatric intensive care of hospital and Willingness of legally acceptable representative of patient to give written informed consent
Exclusion Criteria
Patents admitted before the initiation of study were not included
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients receiving either vancomycin or colistin or meropenem or imipenem or piperacillin-tazobactum or in combination with each otherTimepoint: From day 1 of admission till discharge, transfer or death
- Secondary Outcome Measures
Name Time Method To assess the proportion of antibacterials prescribed on the basis of culture and sensitivity report and to calculate the cost of antibacterial drug treatmentTimepoint: From day 1 of admission till discharge, transfer or death